Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Microgenics Corporation

QualityClass II recall21 Oct 2026

Microgenics Corporation

21 Oct 2026: Class II recall · MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control, . Recorded in the openFDA device enforcement reports.

View the source record

Reported
21 Oct 2026
Recall Class
Class II
Product
MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, REF: OPRO-101; MAS Omni IMMUNETM PRO Liquid Assayed Integrated Immunoassay Control,
Reason
Vial-to-vial variability in MAS¿ Omni"IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, Lot OPRO29061A results in low Parathyroid Hormone (PTH) recovery, which may lead to a delay in reporting patient PTH results.
Country
United States
Status
Ongoing
Reference
Z-0159-2027
Location
Fremont, CA
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Microgenics Corporation

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.